GCTK — GlucoTrack Balance Sheet
0.000.00%
- $7.23m
- $5.93m
Annual balance sheet for GlucoTrack, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
R2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-Q | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 0.419 | 9.82 | 6.06 | 2.31 | 4.49 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.07 | 0.066 | 0 | — | — |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 0.718 | 10.2 | 6.11 | 2.38 | 4.87 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.321 | 0.315 | 0.109 | 0.04 | 0.027 |
Other Long Term Assets | |||||
Total Assets | 1.1 | 10.6 | 6.26 | 2.44 | 4.91 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 2.27 | 1.34 | 0.883 | 1.01 | 1.51 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 2.51 | 1.62 | 1.11 | 1.21 | 1.71 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | -1.41 | 8.98 | 5.16 | 1.23 | 3.2 |
Total Liabilities & Shareholders' Equity | 1.1 | 10.6 | 6.26 | 2.44 | 4.91 |
Total Common Shares Outstanding |